Prescription drugs sales at 340B prices were $38.8 billion in 2020, a new PhRMA-funded study says.

340B Sales Were $38.8 Billion in 2020, PhRMA-Funded Study Finds

Prescription drugs sales at 340B prices were $38.8 billion in 2020, “more than three times the level of 340B sales compared to just five years prior,” new drug industry funded research shows.

Total sales would have been $93.6 billion if drug manufacturers could have charged covered entities wholesale prices instead of 340B ceiling prices, according to the June 30 report by Berkeley Research Group funded by Pharmaceutical Research and Manufacturers of America.

Prescription drugs sales at 340B prices were $38.8 billion in 2020, “more than three times the level of 340B sales compared to just five years prior,” new drug industry funded research shows.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer